Sales rise 17.43% to Rs 1457.10 crore
Net profit of Alembic Pharmaceuticals rose 35.37% to Rs 333.37 crore in the quarter ended September 2020 as against Rs 246.27 crore during the previous quarter ended September 2019. Sales rose 17.43% to Rs 1457.10 crore in the quarter ended September 2020 as against Rs 1240.87 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales1457.101240.87 17 OPM %30.4327.84 -PBDT442.17338.80 31 PBT398.39302.85 32 NP333.37246.27 35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
